title: Prevalence of age-related maculopathy and age-related macular degeneration among the inuit in Greenland. The Greenland Inuit Eye Study.
abstract: OBJECTIVE
  To examine the age- and gender-specific prevalence and describe the common phenotype of early age-related maculopathy (ARM) and late-stage age-related macular degeneration (AMD) among the Inuit in Greenland.
  
  
  METHODS
  Population-based cross-sectional study.
  
  
  METHODS
  All > or =60-year-olds born in Greenland and living in the communities of Nuuk and Sisimiut, Greenland.
  
  
  METHODS
  The presence and form of early (ARM) and late age-related macular disease (AMD) were determined by grading color fundus photographs using the international classification and grading system for ARM and AMD.
  
  
  METHODS
  Prevalences of ARM and AMD were assessed by masked grading of fundus photographs.
  
  
  RESULTS
  Overall, 695 persons were included in the study (response rate, 74.8%). Prevalence of any ARM was 52.3%. Age-related maculopathy was present in the worse eye in 50.0%, 58.8%, and 44.7% of age groups 60 to 69, 70 to 79, and > or =80, respectively. Prevalence of any AMD was 9.5%. Any AMD was present in the worse eye in 3.9%, 14.6%, and 43.2% of age groups 60 to 69, 70 to 79, and > or =80. Prevalences of pure geographic atrophy (GA) in one or both eyes, exudative degeneration in one or both eyes, and GA in one eye and exudative degeneration in the other eye were 2.3%, 6.1%, and 1.1%, respectively.
  
  
  CONCLUSIONS
  The prevalence of ARM is higher than in most other populations studied, and the prevalence of AMD in the oldest age group is higher than in most other populations studied. The prevalence of exudative degeneration is higher than the prevalence of GA, in contrast to findings in some of the Nordic countries-particularly Iceland-and earlier observations in Greenland.
authors.affiliation: Department of Ophthalmology, Rigshospitalet, University Hospital of Copenhagen and Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
authors.forename: Mads Varis Nis
authors.initials: MV
authors.lastname: Andersen
authors.forename: Thomas
authors.initials: T
authors.lastname: Rosenberg
authors.forename: Morten
authors.initials: M
authors.lastname: la Cour
authors.forename: Jens F
authors.initials: JF
authors.lastname: Kiilgaard
authors.forename: Jan U
authors.initials: JU
authors.lastname: Prause
authors.forename: Poul Helge
authors.initials: PH
authors.lastname: Alsbirk
authors.forename: Knut
authors.initials: K
authors.lastname: Borch-Johnsen
authors.forename: Tunde
authors.initials: T
authors.lastname: Peto
authors.forename: Bendix
authors.initials: B
authors.lastname: Carstensen
authors.forename: Alan C
authors.initials: AC
authors.lastname: Bird
mesh_terms: D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001284:Atrophy; D003430:Cross-Sectional Studies; D005122:Exudates and Transudates / Q000378:metabolism; D005123:Eye / Q000378:metabolism / Q000473:pathology; D005260:Female; D005654:Fundus Oculi; D006116:Greenland / Q000453:epidemiology; D006801:Humans; D004930:Inuit / Q000706:statistics & numerical data*; D008268:Macular Degeneration / Q000175:diagnosis / Q000208:ethnology* / Q000235:genetics / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D015995:Prevalence